Published in BMC Genomics on May 20, 2014
The structural basis for cancer treatment decisions. Oncotarget (2014) 1.05
Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell Int (2015) 0.88
SNP-SIG 2013: from coding to non-coding--new approaches for genomic variant interpretation. BMC Genomics (2014) 0.85
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer. PLoS One (2015) 0.85
Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy. Cancers (Basel) (2014) 0.79
Identifying mutation specific cancer pathways using a structurally resolved protein interaction network. Pac Symp Biocomput (2015) 0.78
Single Nucleotide Polymorphisms in IL-10, IL-12p40, and IL-13 Genes and Susceptibility to Glioma. Int J Med Sci (2015) 0.77
Interleukin-10 Family and Tuberculosis: An Old Story Renewed. Int J Biol Sci (2016) 0.77
A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway. Biophys J (2015) 0.76
Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes. Drug Des Devel Ther (2015) 0.76
The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis. Sci Rep (2016) 0.75
IL-10 and PRKDC polymorphisms are associated with glioma patient survival. Oncotarget (2016) 0.75
Regional tissue immune responses after sciatic nerve injury in rats. Int J Clin Exp Med (2015) 0.75
Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis. J Cancer Res Clin Oncol (2016) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Inflammation and cancer. Nature (2002) 53.78
Cancer-related inflammation. Nature (2008) 34.21
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc (2010) 22.66
STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2012) 18.26
The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet (2008) 16.09
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med (1989) 15.15
TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res (2005) 14.15
Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field. Proteins (2002) 6.21
Cancer: an inflammatory link. Nature (2004) 3.88
Interleukin-10 therapy--review of a new approach. Pharmacol Rev (2003) 3.51
Biology of interleukin-10. Cytokine Growth Factor Rev (2010) 3.41
Principles of protein-protein interactions: what are the preferred ways for proteins to interact? Chem Rev (2008) 2.96
Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol (2012) 2.67
The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res (1999) 2.66
Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol (2012) 2.35
Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol (2005) 2.24
PRISM: protein interactions by structural matching. Nucleic Acids Res (2005) 2.11
Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J (1997) 2.03
Interactome3D: adding structural details to protein networks. Nat Methods (2012) 1.89
Cytokines as a key component of cancer-related inflammation. Cytokine (2008) 1.85
Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM. Nat Protoc (2011) 1.84
Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem (1999) 1.77
Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem (1997) 1.67
Protein interactions in human genetic diseases. Genome Biol (2008) 1.52
A graphical interface for the FoldX forcefield. Bioinformatics (2011) 1.50
Physiological functions of APP family proteins. Cold Spring Harb Perspect Med (2012) 1.44
Protein-protein interfaces: architectures and interactions in protein-protein interfaces and in protein cores. Their similarities and differences. Crit Rev Biochem Mol Biol (1996) 1.43
Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem (2002) 1.42
Chemokines in cancer related inflammation. Exp Cell Res (2010) 1.40
Dual biological effects of the cytokines interleukin-10 and interferon-γ. Cancer Immunol Immunother (2011) 1.34
Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem (2006) 1.31
HotPoint: hot spot prediction server for protein interfaces. Nucleic Acids Res (2010) 1.30
Soluble mediators of inflammation during tumor development. Adv Cancer Res (2005) 1.24
Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Res (2011) 1.22
Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. Cancer Res (2003) 1.20
Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Cancer Res (2009) 1.20
Trial Watch: Immunostimulatory cytokines. Oncoimmunology (2012) 1.19
alpha2-Macroglobulin and haptoglobin suppress amyloid formation by interacting with prefibrillar protein species. J Biol Chem (2008) 1.18
α-2-Macroglobulin: a physiological guardian. J Cell Physiol (2013) 1.13
Favorable scaffolds: proteins with different sequence, structure and function may associate in similar ways. Protein Eng Des Sel (2005) 1.12
Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int J Cancer (2001) 1.08
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma. Clin Cancer Res (2008) 1.08
Constructing structural networks of signaling pathways on the proteome scale. Curr Opin Struct Biol (2012) 1.07
Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs. J Proteome Res (2012) 1.05
Fast and accurate modeling of protein-protein interactions by combining template-interface-based docking with flexible refinement. Proteins (2012) 1.05
Prediction of protein-protein interactions: unifying evolution and structure at protein interfaces. Phys Biol (2011) 1.04
A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J (2003) 1.02
Pro- and anti-inflammatory cytokine content in human peripheral blood after its transcutaneous (in vivo) and direct (in vitro) irradiation with polychromatic visible and infrared light. Photomed Laser Surg (2006) 0.99
The structural network of inflammation and cancer: merits and challenges. Semin Cancer Biol (2013) 0.99
Enriching the human apoptosis pathway by predicting the structures of protein-protein complexes. J Struct Biol (2012) 0.98
Exploiting conformational ensembles in modeling protein-protein interactions on the proteome scale. J Proteome Res (2013) 0.96
From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells. Proc Natl Acad Sci U S A (1998) 0.95
Binding of IL-1 beta to alpha-macroglobulins and release by thioredoxin. J Immunol (1990) 0.93
Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J Biol Chem (2000) 0.90
Interleukin-4 and IL-10 bind covalently to activated human alpha2-macroglobulin by a mechanism that requires Cys949. J Interferon Cytokine Res (2000) 0.90
A strategy based on protein-protein interface motifs may help in identifying drug off-targets. J Chem Inf Model (2012) 0.90
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response. Curr Opin Immunol (2013) 0.89
Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis. Mol Cancer (2012) 0.87
Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues. Prostate Cancer Prostatic Dis (2003) 0.85
Integrating structure to protein-protein interaction networks that drive metastasis to brain and lung in breast cancer. PLoS One (2013) 0.85
The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. PLoS Comput Biol (2014) 0.84
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker. J Clin Oncol (2004) 0.84
Elevated levels of serum alpha(2) macroglobulin in wild black bears during hibernation. Biochimie (2003) 0.82
Inflammation in cancer: a therapeutic target? Oncology (Williston Park) (2011) 0.82
Inhibition of interleukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses. Cancer Immunol Immunother (2000) 0.82
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer. Br J Cancer (2002) 0.82
Human kallikrein 13 expression in salivary gland tumors. Int J Biol Markers (2006) 0.79
Alpha 2-macroglobulin. A multifunctional binding and targeting protein with possible roles in immunity and autoimmunity. Ann N Y Acad Sci (1994) 0.79
XIAP: inhibitor of two worlds. EMBO J (2013) 0.78
Human tissue kallikreins and testicular cancer. APMIS (2003) 0.77
Complex formation between human kallikrein 13 and serum protease inhibitors. Clin Chim Acta (2004) 0.76
PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res (2005) 7.66
The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol (2009) 7.36
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell (2009) 7.09
Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins (2002) 5.79
Is allostery an intrinsic property of all dynamic proteins? Proteins (2004) 4.99
A method for simultaneous alignment of multiple protein structures. Proteins (2004) 3.45
Protein-protein interactions: structurally conserved residues distinguish between binding sites and exposed protein surfaces. Proc Natl Acad Sci U S A (2003) 3.42
Allostery: absence of a change in shape does not imply that allostery is not at play. J Mol Biol (2008) 3.24
Hot regions in protein--protein interactions: the organization and contribution of structurally conserved hot spot residues. J Mol Biol (2004) 3.10
Stabilities and conformations of Alzheimer's beta -amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects. Proc Natl Acad Sci U S A (2002) 3.06
Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations. Protein Sci (2002) 3.01
Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem Sci (2010) 2.97
Principles of protein-protein interactions: what are the preferred ways for proteins to interact? Chem Rev (2008) 2.96
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res (2004) 2.95
FireDock: fast interaction refinement in molecular docking. Proteins (2007) 2.90
Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging (2013) 2.72
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther (2013) 2.64
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat Commun (2010) 2.49
Close-range electrostatic interactions in proteins. Chembiochem (2002) 2.42
FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res (2008) 2.39
The origin of allosteric functional modulation: multiple pre-existing pathways. Structure (2009) 2.33
Recognition of functional sites in protein structures. J Mol Biol (2004) 2.32
Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma. Clin Cancer Res (2007) 2.21
Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms. Mol Biosyst (2009) 2.18
Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer (2002) 2.16
Extended disordered proteins: targeting function with less scaffold. Trends Biochem Sci (2003) 2.12
A new, structurally nonredundant, diverse data set of protein-protein interfaces and its implications. Protein Sci (2004) 2.11
PRISM: protein interactions by structural matching. Nucleic Acids Res (2005) 2.11
Protein-protein interactions; coupling of structurally conserved residues and of hot spots across interfaces. Implications for docking. Structure (2004) 2.06
Noninvasive assessment of LV contraction patterns using CMR to identify responders to CRT. JACC Cardiovasc Imaging (2013) 2.06
Residues crucial for maintaining short paths in network communication mediate signaling in proteins. Mol Syst Biol (2006) 1.98
A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status. Clin Cancer Res (2007) 1.96
Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking. Proteins (2003) 1.95
Geometry-based flexible and symmetric protein docking. Proteins (2005) 1.95
Flexible protein alignment and hinge detection. Proteins (2002) 1.93
Relationship between ion pair geometries and electrostatic strengths in proteins. Biophys J (2002) 1.91
Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood (2006) 1.86
HingeProt: automated prediction of hinges in protein structures. Proteins (2008) 1.86
Prediction of protein-protein interactions by combining structure and sequence conservation in protein interfaces. Bioinformatics (2005) 1.86
Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM. Nat Protoc (2011) 1.84
Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology (2008) 1.82
PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. Clin Cancer Res (2013) 1.81
Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J Mol Biol (2008) 1.80
Identification of computational hot spots in protein interfaces: combining solvent accessibility and inter-residue potentials improves the accuracy. Bioinformatics (2009) 1.80
Principles of flexible protein-protein docking. Proteins (2008) 1.71
Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. Curr Opin Chem Biol (2006) 1.70
ARTS: alignment of RNA tertiary structures. Bioinformatics (2005) 1.67
Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res (2004) 1.65
Protein-protein interactions: hot spots and structurally conserved residues often locate in complemented pockets that pre-organized in the unbound states: implications for docking. J Mol Biol (2004) 1.64
Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape. Chem Rev (2010) 1.62
Enzyme dynamics point to stepwise conformational selection in catalysis. Curr Opin Chem Biol (2010) 1.61
Similar binding sites and different partners: implications to shared proteins in cellular pathways. Structure (2007) 1.60
Molecular dynamics simulations of alanine rich beta-sheet oligomers: Insight into amyloid formation. Protein Sci (2002) 1.59
Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat Neurosci (2011) 1.58
Dynamic allostery: linkers are not merely flexible. Structure (2011) 1.58
Correlated mutations: advances and limitations. A study on fusion proteins and on the Cohesin-Dockerin families. Proteins (2006) 1.58
Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol (2009) 1.54
Analysis of ordered and disordered protein complexes reveals structural features discriminating between stable and unstable monomers. J Mol Biol (2004) 1.54
Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther (2006) 1.54
HotSprint: database of computational hot spots in protein interfaces. Nucleic Acids Res (2007) 1.54
MultiBind and MAPPIS: webservers for multiple alignment of protein 3D-binding sites and their interactions. Nucleic Acids Res (2008) 1.52
Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer. Clin Cancer Res (2008) 1.52
ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. Cancer Res (2011) 1.52
Architectures and functional coverage of protein-protein interfaces. J Mol Biol (2008) 1.51
2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Clin Cancer Res (2004) 1.50
Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome. Proc Natl Acad Sci U S A (2010) 1.48
A survey of available tools and web servers for analysis of protein-protein interactions and interfaces. Brief Bioinform (2009) 1.47
FiberDock: Flexible induced-fit backbone refinement in molecular docking. Proteins (2010) 1.47
Emergence of protein kinase CK2 as a key target in cancer therapy. Biofactors (2010) 1.46
Acidic preconditioning protects against ischemia-induced brain injury. Neurosci Lett (2012) 1.45
Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. Biophys J (2007) 1.44
Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities. Biophys J (2007) 1.44
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.44
New structures help the modeling of toxic amyloidbeta ion channels. Trends Biochem Sci (2008) 1.43
Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: significant role of Asn ladder. Proc Natl Acad Sci U S A (2005) 1.43